Unknown OBSERVATIONAL NCT05041777

Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma (OCT-BCC)

Sponsor: Maastricht University

Conditions Artificial Intelligence Basal Cell Carcinoma Deep Learning Optical Coherence Tomography

Interventions Optical Coherence Tomography

Updated 4 times since 2021 Last updated: Sep 3, 2021 Started: Feb 15, 2017 Primary completion: Apr 30, 2021 Completion: Dec 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Artificial Intelligence and Basal Cell Carcinoma, this trial is ongoing. The trial is conducted by Maastricht University and has accumulated 4 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jun 2023 — Jul 2024 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Oct 2021 — Jun 2023 [monthly]

Active Not Recruiting

First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maastricht University
Maastricht University Medical Center

Data source: Maastricht University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maastricht, Netherlands